<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Causes and diagnostic features of PEEVO</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Causes and diagnostic features of PEEVO</h1>
<div class="graphic"><div class="figure"><div class="ttl">Causes and diagnostic features of PEEVO</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="12.5%"></colgroup><colgroup span="3" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Cause of PEEVO</td> <td class="subtitle1">Fluid type</td> <td class="subtitle1">Patient characteristics</td> <td class="subtitle1">Pleural fluid characteristics</td> <td class="subtitle1">Diagnostic test</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Transudative PEEVO</td> </tr> <tr> <td class="indent1">PDAPE</td> <td>Peritoneal dialysate</td> <td>Unilateral effusion in patient undergoing peritoneal dialysis (fluid migrates across the diaphragm)</td> <td>Clear fluid, transudate with very low protein</td> <td>Glucose = 200 to 2000 mg/dL, PF/S glucose &gt;1</td> </tr> <tr> <td class="indent1">Urinothorax</td> <td>Urine</td> <td> <p>Ipsilateral effusion in a patient with obstructive uropathy or iatrogenic/traumatic injury to GU tract</p> Urinoma may be present on imaging</td> <td>Serous, transudate with very low protein (&lt;1 mg/dL), pH &lt;7.40</td> <td>PF/S creatinine &gt;1 (supportive) &gt;1.7 (diagnostic)</td> </tr> <tr> <td class="indent1">EVM of CVC</td> <td>Intravenous fluid</td> <td>Ipsilateral effusion in a patient with newly placed CVC (catheter migrates through the posterior venous wall and mediastinal pleura)</td> <td>Serosanguinous (if mixed with blood) transudate with very low protein, IV fluid content*</td> <td>Content reflective of infusate (eg, high glucose if dextrose)</td> </tr> <tr> <td class="indent1"> <p>VP or VPL shunt</p> DPF</td> <td>CSF</td> <td> <p>Effusion in patient with VP or VPL shunt</p> Patient with an effusion who has a spinal cord tumor or is status post a neurosurgical procedure (eg, laminectomy, discectomy) or thoracic surgery (eg, thoracotomy or thoracoscopy)</td> <td>"Clear water," transudate with very low protein (&lt;1 mg/dL)</td> <td>Beta<sub>2</sub> transferrin present</td> </tr> <tr> <td class="indent1">Glycinothorax</td> <td>Irrigation fluid rich in glycine</td> <td>Effusion in a patient undergoing irrigation for transurethral bladder surgery</td> <td>Clear fluid, transudate</td> <td>PF/S glycine 300:1 or higher</td> </tr> <tr> <td class="indent1">Hepatic hydrothorax</td> <td>Ascites</td> <td>Effusion in a patient with portal hypertension</td> <td>Clear transudate similar to ascites (unless infected)</td> <td>Clinical diagnosis of exclusion</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Exudative PEEVO</td> </tr> <tr> <td class="indent1">Esophageal or gastric perforation</td> <td>Infected or esophageal/gastric contents</td> <td>Unilateral, often left-sided effusion in a patient with injury or pathology of the esophagus or stomach</td> <td>Purulent, foul odor, exudate with high PMN, LDH &gt;1000 IU/L, Ph5-7</td> <td> <p>PF/S amylase &gt;1</p> <p>Salivary isoenzyme</p> Food particles</td> </tr> <tr> <td class="indent1">Enteral feeding tube migration</td> <td>Enteral formula</td> <td>Patient with effusion (often left-sided) after misplacement of feeding tube (penetration of esophagus or tracheobronchial tree)</td> <td>Milky fluid, exudate</td> <td>TG &gt;110 mg/dL [1.24 mmol/L], PF/S glucose &gt;1</td> </tr> <tr> <td class="indent1">Pancreaticopleural fistula</td> <td>Pancreatic fluid</td> <td>Right-sided effusion in patient with chronic pancreatitis or pseudocyst</td> <td>Turbid yellow, exudate</td> <td>Amylase &gt;100,000 IU/L (pancreatic isoenzyme)</td> </tr> <tr> <td class="indent1">Bilothorax</td> <td>Bile</td> <td>Right-sided effusion following injury to the biliary tree, or from biliary tract obstruction or from parasitic infection of liver, or sub diaphragmatic abscess</td> <td>Green and turbid, exudate with signs of infection (eg, high white blood cell count, high percentage of neutrophil, high lactate dehydrogenase, pH &lt;7.2, low glucose)</td> <td>PF/S bilirubin &gt;1 (organisms may be present)</td> </tr> <tr> <td class="indent1">Chylothorax</td> <td>Chyle (lymphatic fluid)</td> <td>Effusion in patients with lymphatic pathology (eg, tumors, trauma, LAM)</td> <td>Milky fluid, exudate</td> <td>TG &gt;110 mg/dL [1.24 mmol/L] and/or detection of chylomicrons</td> </tr> <tr> <td class="indent1">Cholesterol effusion</td> <td>Cholesterol</td> <td>Effusion in a patient with tuberculosis or rheumatoid arthritis</td> <td>Milky fluid exudate</td> <td>Pleural fluid cholesterol level ≥200 mg/dL [≥5.18 mmol/L], a cholesterol to triglyceride ratio &gt;1 in the pleural fluid, chylomicrons absent</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>PEEVO: pleural effusion of extra-vascular origin; PDAPE: peritoneal dialysis-associated pleural effusion; PF/S: pleural fluid to serum ratio; EVM: extravascular migration; CVC: central venous catheter; VP: ventriculoperitoneal; VPL: ventriculopleural; CSF: cerebrospinal fluid; DPF: duropleural fistula; PMN: polymorphonuclear neutrophil; LDH: lactate dehydrogenase; TG: triglyceride; LAM: lymphangioleiomyomatosis.</p>
* Exception is when total parenteral nutrition or lipids are being infused, in which case protein is present and fluid will be milky, respectively.</div><div id="graphicVersion">Graphic 122224 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
